Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy

Volume:14   Issue: 5
Pp: 419-433
Ankit Saneja, Ravindra Dhar Dubey, Noor Alam, Vaibhav Khare and Prem N. Gupta
DOI: 10.2174/1568009614666140407112034

The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer

Volume:14   Issue: 5
Pp: 446-457
Wanxing Duan, Jiguang Ma, Qingyong Ma, Qinhong Xu, Jianjun Lei, Liang Han, Xuqi Li, Zheng Wang, Zheng Wu, Shifang Lv, Zhenhua Ma, Mouzhu Liu, Fengfei Wang and Erxi Wu
DOI: 10.2174/1568009614666140402105101

Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review

Volume:14   Issue: 5
Pp: 458-476
P.D. Marcato, W.J. Favaro and N. Duran
DOI: 10.2174/1568009614666140508154020

Prognostic and Predictive Biomarkers in Cancer

Volume:14   Issue: 5
Pp: 477-504
Meera Nair, Sardul Singh Sandhu and Anil K. Sharma
DOI: 10.2174/1568009614666140506111118